The AlphaLISA™ SureFire® Biotin-Free Human and Mouse Total ATF-3 assay is a sandwich immunoassay for quantitative detection of total ATF-3 in cellular lysates using Alpha Technology.
| Feature | Specification |
|---|---|
| Application | Cell Signaling |
| Protocol Time | 2h at RT |
| Sample Volume | 10 µL |
The AlphaLISA™ SureFire® Biotin-Free Human and Mouse Total ATF-3 assay is a sandwich immunoassay for quantitative detection of total ATF-3 in cellular lysates using Alpha Technology.
Loading...
Activating Transcription Factor 3 (ATF-3) is a stress-inducible member of the ATF/CREB family of basic leucine zipper (bZIP) transcription factors that is rapidly upregulated in response to diverse cellular stresses including DNA damage, oxidative stress, cytokines, and growth factor withdrawal. ATF-3 can function as either a transcriptional repressor or activator depending on its dimerization partner; as a homodimer it typically represses transcription, while heterodimers with other bZIP proteins such as ATF2, c-Jun, or c-Fos can activate target gene expression. ATF-3 regulates genes involved in apoptosis, inflammation, cell cycle arrest, and metabolic adaptation, positioning it as a key integrator of stress response programs. In cancer, ATF-3 exhibits context-dependent roles: it functions as a tumor suppressor in colorectal and prostate cancers by promoting apoptosis and inhibiting invasion, but can also support tumor progression in breast cancer by modulating the tumor microenvironment and promoting metastasis. ATF-3 has also been implicated in immune regulation, where it modulates Toll-like receptor signaling and inflammatory cytokine production in macrophages, linking it to innate immunity and inflammatory disease.
The AlphaLISA SureFire Biotin-Free Human and Mouse Total ATF-3 Detection Kit is a sandwich immunoassay for the quantitative detection of total ATF-3 in cellular lysates, using Alpha Technology.
Formats:
AlphaLISA SureFire Biotin Free kits are compatible with:
AlphaLISA SureFire Biotin Free kits can be used for:
The Total-AlphaLISA SureFire Biotin Free assay measures the expression level of a target protein in a biological sample (e.g. cell lysate).
The Total-AlphaLISA SureFire Biotin Free assay uses two antibodies which recognize two different distal epitopes on the target protein. AlphaLISA assays require two bead types: Acceptor and Donor Beads. Acceptor Beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor Beads are coated with a proprietary CaptSure3 agent to capture one of the detection antibodies, which is labeled with the CaptSure3 tag. In the presence of target protein, the two antibodies bring the Donor and Acceptor Beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor Bead, allowing for the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.
The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Biotin Free detection reagents. This protocol enables cell viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.
Detection of Total target protein with AlphaLISA SureFire Biotin Free reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining robust AlphaLISA SureFire quality.
RPMI 8226 cells were seeded in a 96-well plate (200,000 cells/well) in complete medium and treated with 1 µg/mL LPS for the indicated times at 37°C, 5% CO2.
After treatment, the cells were spun down and lysed with 65 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). ATF-3 levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of cell lysate (approximately 30,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, LPS treatment induced ATF-3 expression after 2 hours, reaching maximal levels after 6 hours.
RPMI 8226 cells were seeded in a 96-well plate (200,000 cells/well) in complete medium and treated with 5 µM R848 at indicated times at 37°C, 5% CO2.
After treatment, the cells were spun down and lysed with 50 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). ATF-3 levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of cell lysate (approximately 40,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
R848 is a TLR7/8 agonist that mimics pathogen-associated molecular patterns triggering innate immune responses. R848 induced ATF-3 expression after 2 hours, reaching maximal levels after 6 hours.
RPMI 8226 cells were seeded in a 96-well plate (200,000 cells/well) in complete medium and treated with increasing concentrations of LPS for 4 hours at 37°C, 5% CO2.
After treatment, the cells were spun down and lysed with 65 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). ATF-3 Total and IRF5 Total levels were evaluated using respective AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 30,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, LPS treatment resulted in a dose dependent increase in the levels of ATF-3 with no significant changes in IFR5 Total signal.
RAW 264.7 cells were seeded in a 96-well plate (60,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. Cells were treated with increasing concentrations of LPS for 4 hours.
After treatment, the cells were lysed with 30 µL or 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). ATF-3 and ERK Total levels were evaluated using respective AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 20,000 cells for ATF-3 Total and 6,000 cells for ERK Total) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, LPS resulted in a dose dependent increase in the levels of ATF-3 while ERK Total levels remained unchanged.
ATF-3 levels were assessed in HCT-116 (WT) and ATF-3 KO (Abcam, ab266872) cell lines cultured to confluency in T175 flasks at 37°C, 5% CO2. Cells were lysed in 4 mL of Lysis Buffer for 10 minutes at RT with shaking.
Lysate was serially diluted in Lysis Buffer and ATF-3 levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
Approximate number of cells per datapoint is indicated. The dotted line represents assay background. ATF-3 was detected in WT but not KO cells, confirming the specificity of the assay for the detection of ATF-3 protein.
Adherent cells were grown to confluency in a T175 flask in complete medium and lysed with Lysis Buffer at a density of 2 x 106 cells/mL. Suspension cells were harvested, spun down and lysed with Lysis Buffer at a density of 1.6 x 106 cells/mL.
ATF-3 levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of cell lysate (20,000 adherent and 16,000 suspension cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
ATF-3 is a stress inducible gene and basal expression was detected in a range of human cell lines and in RAW 264.7 mouse cells. As expected HCT-116 cells have elevated endogenous levels of ATF-3.
Cell lysate was prepared from HCT-116 cells cultured to confluence in a T175 flask and lysed in 3 mL of Lysis Buffer for 10 minutes at RT with shaking.
Lysate was serially diluted in Lysis Buffer and ATF-3 levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
Approximate number of cells per datapoint is indicated. The dotted line represents assay background. This assay can detect endogenous ATF-3 expression in less than 2,500 HCT-116 cells.
| Application |
Cell Signaling
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
AlphaLISA SureFire Biotin-Free
|
| Detection Modality |
Alpha
|
| Product Group |
Kit
|
| Protocol Time |
2h at RT
|
| Sample Volume |
10 µL
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target |
ATF-3
|
| Target Class |
Phosphoproteins
|
| Target Species |
Human
Mouse
|
| Technology |
Alpha
|
| Therapeutic Area |
Inflammation
Oncology
|
| Unit Size |
500 Assay Points
|
Are you looking for resources, click on the resource type to explore further.
The definitive guide for setting up a successful AlphaLISA SureFire Ultra assay
Several biological processes are regulated by...
Loading...
We are here to answer your questions.